Equity
€1.8m ▲ 22.0%
CLEERPHARMA has made a profit without a break since 2013.
CLEERPHARMA
Lifetime
20 annual accounts with figures on one time axis, 23 filings since 2003peak €503,810 (2025)
€503,810▲ 44.3%
lowest -€5,180 (2012)
€317,779▲ 31.0%
peak €1.8m (2025)
€1.8m▲ 22.0%
€251,879▼ 10.9%
peak 1.9 FTE (2014)
-not published
Board1 name since 2021
1 director
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from €349,132 to €503,810Result from €242,513 to €317,779Equity from €1.4m to €1.8mCash from €341,853 to €534,688
Key points
from the 2025 annual accountsResult
€317,779 ▲ 31.0%
The result rose in 2025 from €242,513 to €317,779.
Turnover
≈ €1.8m estimated
The accounts state no turnover.
Liquidity
7.83 was 6.19 in 2024
Short-term debts fell from €229,801 to €219,908.
Filings
23 annual accounts since 2003
Ten of the last ten came late. The 2022 accounts came latest: 121 days after the end of the period.
Position in the sector
€317,779
Higher net result than 95% of companies in retail trade. Sector median €4,763 · 25,208 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 20,124 companies had the same profile as CLEERPHARMA has now. Each dot stands for 51 companies, two years later.
95.1%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,124 companies, not a prediction for CLEERPHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0477335614
Resignation: (manager)
Reappointment: (director) · “Toutes opérations se rapportant soit directement soit indirectement à l’exploitation de pharmacies et de…” (deed in French) · holds all the shares · General meeting of 18-10-2023 · Gazette deed
First establishment
Rue Ernest Solvay 58, Les Bons Villers
Incorporation
published on 27-04-2002 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| CLEERPHARMA Les Bons Villers | €2.0m | €503,810 | 87.5% | - |
| BB FARMA MANAGEMENT Riemst | €2.1m | €535,365 | 76.2% | 1.8 |
| APOTHEEK BENEDICTE VAN HEULE Nazareth-De Pinte | €2.0m | €559,161 | 78.2% | 1.6 |
| MOLLEMAN - DE COSTER Wingene | €2.2m | €511,805 | 50.9% | 3.7 |
| APOTHEEK BLINDEMAN Beveren-Kruibeke-Zwijndrecht | €2.0m | €435,894 | 55.2% | 7 |
| PHARMACIE CARLIER-THONET Herstal | €2.2m | €523,897 | 22.7% | 3.3 |
| PHARMACIE HOREMANS Charleroi | €2.2m | €467,185 | 58.2% | 4.8 |
These companies have the same main activity as CLEERPHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €2m and €2.2m, founded between 2000 and 2004.
Official details
Source: KBO- Status
- Active since 15-04-2002Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730and 1 other
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2022
- Establishment unit
- 2.114.050.6626211 Les Bons Villers, since 19-08-2002
- Financial year end
- 31 December
- Peppol
- Reachable since 27-11-2025
Insights on CLEERPHARMA
CLEERPHARMA files the micro format. That format states no turnover. The gross margin rose from €193,858 in 2006 to €503,810 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about CLEERPHARMA
- What is the company number of CLEERPHARMA?
- The company number of CLEERPHARMA is 0477.335.614. The VAT number is the same number with BE in front: BE 0477.335.614.
- Where is CLEERPHARMA based?
- The registered office is at Rue Ernest Solvay 58, 6211 Les Bons Villers.Company details
- What does CLEERPHARMA do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of CLEERPHARMA?
- CLEERPHARMA is a private limited company (BV).
- When was CLEERPHARMA founded?
- CLEERPHARMA was founded on 15-04-2002.
- Is CLEERPHARMA still active?
- Yes, CLEERPHARMA is an active enterprise in the KBO register.
- How many employees does CLEERPHARMA have?
- CLEERPHARMA had an average of 0.8 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
- Which joint committee does CLEERPHARMA fall under?
- In its 2022 annual accounts, CLEERPHARMA states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of CLEERPHARMA?
- The turnover in financial year 2025 is ≈ €1.8m. This figure is estimated from the gross margin of €503,810 and 67 comparable companies (NACE 477). It probably lies between €1.2m and €2.8m. In financial year 2021 turnover was €1.4m.
- Is CLEERPHARMA profitable?
- In financial year 2025, CLEERPHARMA made a profit of €317,779.
- Where can I find the annual accounts of CLEERPHARMA?
- CLEERPHARMA filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of CLEERPHARMA due?
- CLEERPHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.